Guanidinylating Peptide Sequencing for Single-Molecule Protein Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current protein sequencing methods, such as mass spectrometry and Edman degradation, lack single molecule sensitivity and spatial information, while immunohistochemistry provides limited scalability and sequence information.

Innovation Solution

Development of sequencing reagents comprising reactive groups, capture-binding moieties, and linkers, specifically using guanidinylating agents, to form covalent bonds with N-terminal amino acids for sequencing polymeric analytes like peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If mass spectrometry is used for protein sequencing, then protein identification and quantification based on mass/charge ratio is enabled, but single molecule sensitivity is not achieved and spatial information is lost

Engineering Contradiction:
Improveprotein identification precisionVSAvoidsingle molecule sensitivity
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent introduces a solid support with a capture moiety as an intermediary to immobilize and concentrate single protein molecules. This mediator enables the protein to be detected and sequenced at single-molecule levels while maintaining spatial information, resolving the contradiction between measurement precision and quantity detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent transitions from solution-based mass spectrometry to a spatially-resolved solid support system. By anchoring proteins to a solid support with specific capture moieties, the method adds spatial dimensionality, enabling single-molecule detection while preserving location information that was lost in traditional MS approaches.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If Edman degradation is used for protein sequencing, then sequential N-terminal amino acid removal and identification is achieved, but throughput is low and harsh reaction conditions are required

Engineering Contradiction:
Improveamino acid sequencing precisionVSAvoidsequencing throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent replaces the mechanical/chemical Edman degradation process with a enzymatic approach using proteases. This substitution eliminates the need for harsh acid and heat conditions, enabling milder reaction environments while maintaining sequencing capability and improving throughput through enzymatic efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the reaction conditions from harsh (acidic, high temperature) to mild (neutral pH, ambient temperature) by using enzymatic cleavage. This parameter change enables the method to be compatible with sensitive analytes and improves overall productivity without sacrificing sequencing precision.

Inventive Principle:
Principle #35Parameter changes

3Shape

If immunohistochemistry is used for protein identification, then spatial localization is achieved, but sequence information is excluded and scalability is limited

Engineering Contradiction:
Improvespatial localization informationVSAvoidprotein sequence information
Core Design Contradiction:
ShapeVSLoss of information

Solution Approach 1:

The patent merges the spatial localization capability of immunohistochemistry with the sequencing capability of mass spectrometry. By combining capture moieties for spatial anchoring with proteolytic sequencing, the method simultaneously provides both location information and amino acid sequence data, eliminating the information loss present in traditional IHC.

Inventive Principle:
Principle #5Merging (Combining)

4Measurement precision

If traditional protein sequencing methods are used, then protein identification is achieved, but low copy-number proteins remain undetected

Engineering Contradiction:
Improveprotein identification accuracyVSAvoiddetection sensitivity for low copy-number proteins
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The solid support with capture moieties acts as a concentrator and mediator that enables detection of single low-abundance protein molecules. This intermediary system amplifies the signal from rare proteins, making them detectable against background noise and resolving the sensitivity issue for low copy-number proteins.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent segments the detection process into discrete steps: capture, immobilization, proteolytic cleavage, and detection. This segmentation enables systematic analysis of individual protein molecules, improving the ability to detect and quantify low-abundance proteins that were previously undetectable in bulk analyses.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables high-throughput, single molecule sequencing of proteins with spatial information, overcoming the limitations of existing methods by providing efficient and scalable protein identification.

Implementation Method 1

A reactive group configured to form a covalent bond with an N-terminal amino acid of a peptide

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Data Source

PatentUS20260049991A1Single-molecule peptide sequencing using guanidinylating agents
Publication Date: 2026.02.19 GLYPHIC BIOTECHNOLOGIES INC
  • US20260049991A1 patent drawing
  • US20260049991A1 patent drawing
  • US20260049991A1 patent drawing

AI summary

The present disclosure provides reagents and methods useful for single-molecule sequencing of proteins through use of a sequencing reagent of Formula I, IV, IV′, IV″, IV-A, IV-B, or V-C. The reagents and methods described herein provide for high-throughput single molecule and high efficiency protein and peptide sequencing in mild conditions allowing for high resolution investigation of complex biological systems.